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Recently the measurement of cellular DNA content has 
been focused on knowing the extent of cancer extension 
and biological behaviour of the tumor cells as well as on 
producting occurrence of recurrence and the survival time 
in patients with carcinomas of various organs. 
 And also it is well known that tumor markers such as 
CEA, CA19-9 and CA72-2 are of great value in predicting 
recurrence in the follow-up study. It is common that col-
orectal cancers show well differentiated carcinoma which 
demonstrates relatively fair prognosis. However, some 
revealed aggressive and rapid extension of carcinoma, 
indicating a poor prognosis. 
 The purpose of this study is to certify the significance of 
the measurement of cellular DNA content for assessing 
biologic behavior of colorectal cancer in comparison with 
clinicopathologic factors which have been used for assess-
ment of their prognosis. 
 Development of flow cytometer enabled us to measure 
the nuclear DNA content with ease, speed and produci-
bility. Furthermore, prevalence of flow cytometric tech-
nique makes it possible to know more accurate outcome. 
When assessed biologically aggressive behavior of tumor 
cells, potent chemotherapy and extensive surgery are 
mandatory for improvement of the outcome. 
 It is necessary to search for the method of the accurate 
assessment of the outcome for patients with carcinomas. 
 The purpose of this study is to clarify the validity of 
nuclear DNA measurement for assessment of the prognosis 
in patients with colorectal cancer in comparison with clini-
copathologic factors.
Material and Methods 
During the period from 1980 to 1987, 226 patients with 
colorectal cancer were operated upon at the First Depart-
ment of Surgery, Nagasaki University School of Medicine. 
The 5-year survival time was compared with the result of 
DNA analysis. 
 The surgical specimens were histologically examined. A 
paraffin block containing tumor extending through muscu-
laris propria was selected. A 5,am slide was cut and stained 
with hematoxylin and esosin. Examination of the slide 
allowed identification of regions where viable tumor tissues 
were separated. The corresponding area was indented into 
the paraffin block. 
 A nuclear suspension was prepared using the technique 
described by Hedley et al in 1983. 
 The sample were analysed by using an FACS N flow 
cytometer. Their coefficient of variation had to be less than 
8%. 
 A DNA index was calculated by equation of mean 
channel number of this second population divided by the 
channel number of the first population, CEA level were 
measured by using IMX Dinamic Kit. The cut-off value of 
CEA was regarded as 2.5ng/ml.
Results 
The surgical specimens from 226 patients with colorectal 
cancer were subjected in this study. As a result of DNA 
analysis, diploid pattern included 83 patients (61 men and 
22 women) and aneuploid contained 14 3patients. (Table 2) 
  Between the two groups in the DNA analysis, there was 
no significant difference in the histologic findings such as 
depth of cancer, node metastasis, peritoneal dissemination, 
hepatic metastasis, histologic cell differentiation and vas-
cular invasion of lymphatic and blood vessels as shown in 
Table 1 and 3. 
 As for surgical curability, relative curability is somewhat 
frequent in aneuploid patients in reflection of advances in 
cancer infiltration in spite of not statistically significant 
difference. 
 With respect to the depth of cancer infiltration, deeply 
invasive cancer extension and node involvement were more 
often in patients with aneuploid than diploid pattern. It is 
indicated that aneuploidy pattern is dominant for the depth 
of invasion and node metastasis. However, they were not 
statistically significant. Histologic parameters such as peri-
toneal dissemination, hepatic metastasis and vascular inva-
sion of lymphatic and blood vessels were almost equivant
in the both groups without a significant difference.
Table 1. Peripheral and portal plasma CEA according to Dukes' 
classification
Dukes peripheral portal CEA 
 A 2.6 ± 1.9 2.7 ± 2.2 
 B 4.2 ± 4.9 6.0 ± 7.5 
 C 8.3 ± 12.1 9.9 ± 12.1 
 D 23.0 ± 30.7 45.2 ± 64.7 
               8.0 ± 10.2 13.9 ± 32.3
Table 2. DNA ploidy patterns and clinical features
                S55-62 (226) 
                 diploid Aneuploid
              83 143
   male 61(73.5%) 82(57.3%) 
   female 22(26.5%) 61(42.7%) 
  mean age 62.2 ± 10.9 60.9 ± 11.2 
Curability 69 98 
                 14 45
invasion m 2 1 
       sm 6 3 
      pm 13 6
      ss (al) 32 58
     s (a2) 18 43
     si (ai) 12 32
n nO 54 52 
      nl 18 41
      n2 9 35
      n3 2 11
       n4 4
P PO 79 139 
      P1 2 3 
     P2 1 1 
     P3 0 0 
H HO 81 134 
     H1 1 6 
     H2 1 3
     H3 0 0
well 69 108 
moderate 11 31 
poor 2 4 
mucinous 1 0 
ly0 37 32 
 1 35 65 
 2 11 38 
3 0 8 
vo 48 78 
1 32 53 
2 3 9 
3 0 3 
Stage 
I 17 4 
II 37 48 
III 18 41 
IV 9 35 
V 2 15
Table 3. DNA ploidy patterns and cell differentiation
differentiation Diploid Aneuploid 
   well 69(83.1%) 108(75.5%) 
 moderate 11 (13.3%) 31 (21.7%) 
   poor 2 ( 2.4%) 4 ( 2.8%) 
 mucinous 1 ( 1.2%)
Fig. 1. Relationship between DNA analysis and clinical stages by 
Dukes classification
 According to Dukes classification, a decrease in distri-
bution of diploid patients proportionated to progression of 
the tumor in reverse proportion to aneuploid one as shown 
in Fig. 1. 
 The survival times were compared by DNA index (DI) 
as shown in Fig. 2. 
 The prognosis of patients with diploid DNA was very 
fair. However, the survival times were proportionally short-
ened with an increase in DI in reflection of a satisfactorily 
prognostic parameter. In particular, more than 1.5 of DI 
indicated a poor prognosis. 
 Among aneuploid patterns of DNA analysis, it is shown 
that less than 1.5 of DI provides a longer survival time after 
surgery for patients with colorectal cancer.
Fig. 2. The survival curve according to DI
 On the other hand, the AgNOR counts averaged from 
1.6 to 8.2 and correlated well with the DI values as shown 
in Fig. 2. 
 The tumor marker levels of CEA were compared with 
the DI values as shown in Fig. 3. High levels of CEA of 
more than 2.5ng/ml tend to be kept with an increase in the 
DI values. It was common that high abnormal CEA levels 
were seen in over DI values of 1.4.
Fig. 3. Correlation between the serum CEA levels and DI
Discussion 
Since Hedley" reported the measurement method from 
paraffin-embedded block, an attempt to assess the outcome 
for patients with carcinoma has been made by nuclear 
DNA measurement. 2, 3) 
 The correlation with DNA ploidy pattern and histologic 
factors were evaluated. As a result, it is defined that the 
outcome for patients with aneuploid colon cancer is worse 
than that for diploid one." 11, 12) 
  It is common that colorectal cancer with aneuploidy is 
far advanced. There are some reports that lost colon can-
cers of Dukes C include aneuploidy pattern, '3 in contrast. 
There is no close correlation with histologic factors. Armi-
tage4' reported that most well-differentiated carcinomas 
revealed diploidy pattern and moderately differentiated 
carcinomas tend to show aneuploidy pattern. It is generally 
accepted that DNA pattern is independent parameter to 
assess the outcome of patients with colorectal cancers 
except for histologic types.'," In this series, aneuploidy 
pattern correlated with node metastasis and the depth of 
tumor invasion as reported by Funai." The higher the 
histologic cell differentiation, the more aneuploidy is fre-
quent. 
 The relation between ploidy pattern and CEA in the 
serum was reported by many investigators in gastric can-
cers. These are consistent with the fact that the tissue 
generation of CEA is enhanced in proportion to the degree 
of aneuploidy pattern.
 On the other hand, Rognum10' clarified that when the 
CEA scores in patients with colorectal cancer were figured 
out by factors of the localization of CEA and the serum 
CEA values, these in aneuploid group were higher than 
those in near-diploid one. It is suggested that CEA gener-
ated by aneuploid cells is prone to liberation to the blood 
stream and the serum CEA values correlate with ploidy 
patterns of DNA analysis. 
  On the contrary, there is a report'' that the serum CEA 
levels are not in association with ploidy pattern. The inci-
dence of aneuploidy pattern in colorectal cancers is re-
ported to be 60 to 68 percent. In advanced cancer, DNA 
ploidy is of great value in assessing the prognosis for the 
reason of surgically complete excision of the tumor in early 
cancer. 
  On the other hand, Wolley15' pointed out that most of the 
patients with colon cancer of Dukes C classification re-
vealed non-diploid pattern with a poor prognosis. 
 The relation between CEA levels and ploid pattern was 
also evaluated and there is a high tendency of revealing 
non-diploidy pattern in patients with an abnormal CEA 
level. 
  And also it is indicated, as reported by Sugiyama,9' that 
aneuploidy pattern well correlates with generation of tumor 
markers such as CEA, AFP and HCG. It is also inves-
tigated as to whether cell cyle is suitable for CEA gener-
ation or not. Kuki14I reported that extra-cellular CEA 
content was increased at the phase of cell proliferation 
although intracellular CEA content was reduced at that 
time. It is recognized that CEA generates at the time of Go 
/G, phase to early s stage. 
  An increase in CEA level is attributed to intracellular 
CEA content, localization of CEA in cancer cells, vascular 
invasion and the depth of tumor invasion. 
  It is a fact that CEA production reflects cell proliferation 
and biologic behavior of malignant cells. And also CEA is 
a valuable marker of knowing occurrence of recurrence in 
follow-up study.
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